✦ LIBER ✦

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

✍ Scribed by Oran, B; Giralt, S; Couriel, D; Hosing, C; Shpall, E J; de Meis, E; Khouri, I F; Qazilbash, M; Anderlini, P; Kebriaei, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic hematopoietic stem-cell trans

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Yeshurun, M; Yerushalmi, R; Avigdor, A; Ben- 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

Allogeneic hematopoietic stem-cell trans

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Yerushalmi, R; Nagler, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB

Outcomes of patients with AML and MDS wh

✍ Pollyea, D A; Artz, A S; Stock, W; Daugherty, C; Godley, L; Odenike, O M; Rich, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Full-intensity and reduced-intensity all

✍ Craddock, C F 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB

Features of Epstein-Barr Virus (EBV) rea

✍ Peric, Z; Cahu, X; Chevallier, P; Brissot, E; Malard, F; Guillaume, T; Delaunay, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 349 KB

Engraftment kinetics and hematopoietic c

✍ I. W. Blau; Martin Schmidt-Hieber; N. Leschinger; H. Göldner; W. Knauf; W. Hopfe 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 152 KB